REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

9 Ace Global Technologies Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: 9 Ace Global Technologies Inc. Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The subject is engaged with the research, development, production, and distribution of pharmaceutical products for human use. Activities include the formulation of active pharmaceutical ingredients, manufacturing of medicinal preparations, quality control, regulatory compliance, and supply to healthcare providers and distributors.

Headquarters
Unit 17, Lm Philexcel Business Park M.A. Roxas Highway Clark Freeport Zone
Angeles; Pampanga;

Contact Details: Purchase the 9 Ace Global Technologies Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the 9 Ace Global Technologies Inc. report to view the information.
Incorporation Date:
August 22, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after 9 Ace Global Technologies Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-4.94%▼
Total operating revenue
-4.94%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total Assets
-7.47%▼
Total Equity
0.39%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
-1.65%▼
Quick Ratio
1.59%▲
Cash Ratio
1.39%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo